Bladder cancer surgical management

Bladder cancer surgical management

Bladder cancer surgical management

On this page

🔬 Diagnosis - Staging the Splash Zone

  • Initial Evaluation: Gold standard is cystoscopy for direct visualization of bladder lesions. Urine cytology is an adjunct, high specificity but low sensitivity for low-grade tumors.
  • Definitive Staging: Transurethral Resection of Bladder Tumor (TURBT) is the cornerstone.
    • Provides tissue for histopathology (grade & stage).
    • Determines depth of invasion (T-stage).
    • Must include detrusor muscle in the specimen.

⭐ The single most important prognostic factor is invasion into the muscularis propria (detrusor muscle). This differentiates Non-Muscle Invasive (NMIBC: Ta, Tis, T1) from Muscle-Invasive Bladder Cancer (MIBC: ≥T2).

  • Metastatic Workup: For MIBC, CT/MRI of abdomen/pelvis assesses nodal (N) and distant metastatic (M) disease.

🔪 Management - The Superficial Shave

  • Primary Approach: Transurethral Resection of Bladder Tumor (TURBT) is the initial diagnostic and therapeutic step for non-muscle invasive bladder cancer (NMIBC).
  • Procedure: A resectoscope is inserted via the urethra to resect the tumor from the bladder wall.
  • Goal: Complete resection of all visible tumors.
  • Adjuvant Therapy: Often followed by a single, post-op dose of intravesical chemotherapy (e.g., Mitomycin C) within 24 hours to reduce recurrence.
  • High-Risk NMIBC: May require intravesical Bacillus Calmette-Guérin (BCG) immunotherapy.

Crucial for Staging: The TURBT specimen must contain detrusor muscle to rule out muscle-invasive disease (T2 or higher). Absence of muscle in a high-grade tumor specimen necessitates a repeat TURBT.

TURBT procedure for bladder tumor removal

🔪 Management - Going Deep, Bladder's Out

  • Non-Muscle Invasive (Ta, T1, CIS):

    • Primary: Transurethral Resection of Bladder Tumor (TURBT) for diagnosis & therapy.
    • Adjuvant: Intravesical Bacillus Calmette-Guérin (BCG) or chemotherapy (e.g., Mitomycin C) to ↓ recurrence.
  • Muscle-Invasive (≥T2):

    • Standard: Radical Cystectomy (RC) with Pelvic Lymph Node Dissection (PLND).
    • Urinary Diversion Post-RC:
      • Ileal Conduit: Incontinent diversion (stoma bag). Most common.
      • Neobladder: Continent, orthotopic reservoir from ileum.

⭐ For muscle-invasive disease, radical cystectomy is standard. The extent of pelvic lymph node dissection is a key prognostic and therapeutic factor.

Ileal Conduit: Before and After Surgical Procedure

🌊 Management - Rerouting the River

  • Post-Radical Cystectomy: Urinary diversion is necessary.
  • 1. Ileal Conduit (Incontinent):
    • Most common. A segment of ileum channels urine from ureters to an abdominal stoma.
    • Requires a permanent external urostomy bag.
    • Lower operative complexity.
  • 2. Orthotopic Neobladder (Continent):
    • Intestinal segment (ileum) fashioned into a reservoir, connected to the urethra.
    • Allows volitional voiding (Valsalva).
    • ⚠️ Higher risk of nighttime incontinence & urinary retention.

⭐ A key long-term complication of using intestinal segments is hyperchloremic, non-anion gap metabolic acidosis.

  • Caused by reabsorption of urinary ammonium ($NH_4^+$) and chloride ($Cl^−$).

Ileal conduit vs. cutaneous ureterostomy after cystectomy

⚠️ Complications - The Post-Op Perils

  • TURBT:
    • Immediate: Hematuria, bladder perforation, UTI.
    • Late: Urethral stricture.
  • Radical Cystectomy & Urinary Diversion:
    • General: DVT/PE, infection, prolonged ileus, urine leak.
    • Urinary Diversion (Ileal Conduit) Specific:
      • Uretero-intestinal stricture → hydronephrosis.
      • Parastomal hernia, stomal stenosis.
      • Sexual dysfunction (ED, vaginal shortening).
      • Vitamin B12 deficiency (long-term).

High-Yield: An ileal conduit can cause a hyperchloremic, non-anion gap metabolic acidosis. This occurs because the intestinal segment reabsorbs urinary chloride in exchange for bicarbonate.

⚡ Biggest Takeaways

  • Non-muscle-invasive (NMIBC): Managed with TURBT (transurethral resection). High-risk tumors receive adjuvant intravesical BCG to prevent progression.
  • Muscle-invasive (MIBC): Standard of care is neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy.
  • Radical cystectomy includes pelvic lymph node dissection and requires permanent urinary diversion (e.g., ileal conduit).
  • An ileal conduit is the most common incontinent diversion; a neobladder is a continent, orthotopic option.
  • Partial cystectomy is a rare, bladder-sparing surgery for select solitary tumors.

Practice Questions: Bladder cancer surgical management

Test your understanding with these related questions

A 31-year-old obese Caucasian female presents to the Emergency Department late in the evening for left lower quadrant pain that has progressively worsened over the last several hours. She describes the pain as sharp and shooting, coming and going. Her last bowel movement was this morning. She has also had dysuria and urgency. Her surgical history is notable for gastric bypass surgery 2 years prior and an appendectomy at age 9. She is sexually active with her boyfriend and uses condoms. Her temperature is 99.5 deg F (37.5 deg C), blood pressure is 151/83 mmHg, pulse is 86/min, respirations are 14/minute, BMI 32. On physical exam, she has left lower quadrant tenderness to palpation with pain radiating to the left groin and left flank tenderness on palpation. Her urinalysis shows 324 red blood cells/high power field. Her pregnancy test is negative. What is the next best step in management?

1 of 5

Flashcards: Bladder cancer surgical management

1/7

Short bowel syndrome is most commonly seen in patients who have had _____

TAP TO REVEAL ANSWER

Short bowel syndrome is most commonly seen in patients who have had _____

small intestine resection

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial